SFX by Ex Libris Inc.

Title:	A simple method to cure established tumors by inflammatory killing of normal cells
Source:	Nature Biotechnology [1087-0156] Daniels, Gregory yr:2004

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bonnotte, B. "Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells." Cancer research 63.9 (2003): 2145-9.
description	2.	Chen, Dai-Xiong X. "Purification of heat shock protein 70-associated tumor peptides and their antitumor immunity to hepatoma in mice." Shi Jie Wei Chang Bing Xue Za Zhi （ Ying Wen Ban ） 10.3 (2004): 361-5.
description	3.	Ohashi, Pamela S S. "Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo." Nature medicine 9.12 (2004): 1469-76.
description	4.	Bateman, Andrew R R. "Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells." Cancer research 62.22 (2002): 6566-78.
description	5.	Connor, Thomas J. "Depression, stress and immunological activation: The role of cytokines in depressive disorders." Life Sciences 62.7 (1997): 583-606.
description	6.	Gallucci, S. "Natural adjuvants: endogenous activators of dendritic cells." Nature medicine 5.11 (1999): 1249-55.
description	7.	Takeda, K. "Toll-like receptors." Annual review of immunology 21.1 (2003): 335-76.
description	8.	Stern, A M A. "RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides." Cell 97.7 (1999): 889-901.
description	9.	Cohen, Rivka R. "T cells and autoantibodies to human HSP70 in type 1 diabetes in children." Journal of autoimmunity 20.4 (2003): 313-21.
description	10.	Akira, K. "Toll-like receptor signalling." Nature reviews. Immunology 4.7: 499-511.
description	11.	Medzhitov, Charles A A. "Innate immune recognition." Annual review of immunology 20.1 (2002): 197-216.
description	12.	Akira, S. "Toll-like receptors: critical proteins linking innate and acquired immunity." Nature immunology 2.8 (2001): 675-680.
description	13.	Takeuchi, O. "Pathogen recognition and innate immunity." Cell 124.4 (2006): 783-801.
description	14.	Medzhitov, R. "Toll-like receptor control of the adaptive immune responses." Nature immunology 5.10: 987-995.
description	15.	Anderson, Mark S. "Projection of an immunological self shadow within the thymus by the aire protein." Science 298.5597 (2002): 1395-1401.
description	16.	Rock, Kenneth L L. "Natural endogenous adjuvants." Springer seminars in immunopathology 26.3 (2005): 231-46.
description	17.	Auffinger, B. "Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy." Cell Death and Differentiation 21.7 (2014): 1119-1131.
description	18.	Farilla, L. "Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes." European journal of immunology 32.5 (2002): 1420-7.
description	19.	Ostrand-Rosenberg, S. "Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease." Cancer research 64.6 (2004): 2205-11.
description	20.	De Caterina, R. "Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes." Cardiovascular research 63.4 (2004): 582-92.